Is CALC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CALC. It does not provide personalized investment advice.

CALC (CalciMedica, Inc. Common Stock) Stock Analysis - Financials

CalciMedica, Inc. Common Stock (CALC) is a publicly traded Healthcare sector company. As of August 29, 2026, CALC trades at $0.49 with a market cap of $14.45M and a P/E ratio of -0.23. CALC moved -1.19% today. Year to date, CALC is -93.11%; over the trailing twelve months it is -82.99%. Its 52-week range spans $0.44 to $7.20. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces CALC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CALC's key financials?

CALC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CALC recently traded at $0.49. Market cap is $14.45M. P/E ratio is -0.23. Revenue is $0.

CALC Key Metrics

Key financial metrics for CALC
Metric	Value
Price	$0.49
Market Cap	$14.45M
P/E Ratio	-0.23
EPS	$-1.97
Dividend Yield	0.00%
52-Week High	$7.20
52-Week Low	$0.44
Volume	667.38K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-29.56M
Gross Margin	0.00%

CALC Analyst Consensus

2 analysts cover CALC: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about CALC

What are CALC's key financials?: CALC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CALC recently traded at $0.49. Market cap is $14.45M. P/E ratio is -0.23. Revenue is $0.
Is CALC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CALC. It does not provide personalized investment advice.